Real-World Depression Screening Practices Among Primary Care Providers Across Patient-Level and Provider-Level Characteristics

被引:0
|
作者
Bruni, Teryn [1 ,2 ,9 ]
Smith, Shawna [3 ]
Quigley, Joanna [4 ]
Koval, Elizabeth [5 ]
Lalonde, Leah [6 ]
Maragakis, Alexandros [7 ]
Kilbourne, Amy M. [7 ,8 ]
King, Cheryl [4 ]
Orringer, Kelly [1 ]
Lee, Joyce M. [1 ]
机构
[1] Univ Michigan, Dept Pediat, Michigan Med, Ann Arbor, MI USA
[2] Algoma Univ, Dept Psychol, Sault Ste Marie, ON, Canada
[3] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI USA
[4] Michigan Med, Child & Adolescent Psychiat, Ann Arbor, MI USA
[5] Cent Michigan Univ, Mt Pleasant, MI USA
[6] Eastern Michigan Univ, Dept Psychol, Ypsilanti, MI USA
[7] Amer Coll Greece, Dept Psychol, Athens, Greece
[8] VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA
[9] Algoma Univ, Dept Psychol, 1520 Queen St East, Sault Ste Marie, ON P6A2G4, Canada
基金
美国国家卫生研究院;
关键词
primary care; follow-up; depression; screening; adolescent health/medicine; ADOLESCENT DEPRESSION; HEALTH-PROBLEMS; IDENTIFICATION; OUTCOMES; CHILDREN;
D O I
10.1177/00099228231223782
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
This study examined primary care provider (PCP) alignment with guideline-based care for adolescent depression screening and identified factors associated with post-screening responses. A retrospective chart review was conducted across 17 primary care clinics. Logistical regressions were estimated across provider specialties, sociodemographic factors, and patient clinical histories. Significant differences in follow-up and identification of depression were found among patients with more severe depression presentation. Follow-up screening was also more likely to be completed among patients with private insurance and less likely to occur among Black patients. Patients with significant mental health history of a mood concern, history of being prescribed psychotropic medication, were currently on medications at the time of the screening, or had a history of an internal mental health referral had a higher predicted probability of being identified as depressed on the patient problem list.
引用
收藏
页码:1442 / 1451
页数:10
相关论文
共 38 条
  • [21] Patient-level predictors of detection of depressive symptoms, referral, and uptake of depression counseling among chronic care patients in KwaZulu-Natal, South Africa
    Kemp, Christopher G.
    Mntambo, Ntokozo
    Bachmann, Max
    Bhana, Arvin
    Rao, Deepa
    Grant, Merridy
    Hughes, James P.
    Simoni, Jane M.
    Weiner, Bryan J.
    Gigaba, Sithabisile Gugulethu
    Luvuno, Zamasomi Prudence Busisiwe
    Petersen, Inge
    GLOBAL MENTAL HEALTH, 2020, 7
  • [22] Association of patient characteristics with real-world ROS1 NSCLC testing patterns among community practices in the United States.
    Wong, William Bruce
    Wu, Ning
    Gupta, Ravindra
    Mansfield, Aaron Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] Treatment Patterns, Clinical Characteristics, and Patient-Reported Outcomes Among Patients with Axial Spondyloarthritis Treated in Real-World Rheumatology Practices in the US
    Concoff, Andrew
    Taiji, Riley
    Grennell-Merrick, Linda
    Rodrigues, Jonathan
    McDermot, Courtney
    Niak, Usha Madhukar
    Ionescuittu, Raluca
    Faucher, Ariane
    Vekeman, Francis
    Nguyen, Tim
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2950 - 2951
  • [24] THE COST-EFFECTIVENESS OF SEQUENTIAL FIRST- AND SECOND-LINE TREATMENTS IN METASTATIC RENAL CELL CARCINOMA USING REAL-WORLD DATA AND A PATIENT-LEVEL SIMULATION MODEL
    de Groot, S.
    Blommestein, H.
    Redekop, W.
    Oosterwijk, E.
    Kiemeney, L.
    Uyl-de Groot, C.
    VALUE IN HEALTH, 2013, 16 (07) : A587 - A587
  • [25] A STATISTICAL COMPARISON OF LOGISTIC REGRESSION VERSUS MACHINE LEARNING TREE-BASED CLASSIFICATION METHODS IN PREDICTING CORONARY HEART DISEASE USING REAL-WORLD PATIENT-LEVEL DATA
    Smolen, H.
    VALUE IN HEALTH, 2019, 22 : S563 - S564
  • [26] Long-term outcomes in patients with progressive forms of relapsing MS treated with teriflunomide: Patient-level data from the TEMSO and TOWER extension studies and the real-world setting
    Nelson, Flavia
    Boyko, Alexey
    Thangavelu, Karthinathan
    Mandel, Matt
    Cavalier, Steven
    Truffinet, Philippe
    Liang, Jinjun
    Lebrun-Frenay, Christine
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 145 - 145
  • [27] Individual patient-level data validation of surrogate and modified endpoints for immunotherapy in advanced hepatocellular carcinoma: Post-hoc analysis of IMbrave150 and real-world observations
    Lim, Mir
    Muquith, Maishara
    Miramontes, Bernadette
    Lee, Chieh-Ju
    Huang, Yi-Hsiang
    Hsiehchen, David
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] Long-term outcomes in patients with progressive forms of relapsing MS treated with teriflunomide: patient-level data from the TEMSO and TOWER extension studies and the real-world setting
    Nelson, F.
    Lebrun-Frenay, C.
    Camu, W.
    Boyko, A.
    Thangavelu, K.
    Mandel, M.
    Cavalier, S.
    Truffinet, P.
    Liang, J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 940 - 941
  • [29] A Real-World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment
    Lombard, Louise
    Nutr, M.
    Ye, Wenyu
    Nichols, Russell
    Jackson, James
    Cotton, Sarah
    Joshi, Shivang
    HEADACHE, 2020, 60 (07): : 1325 - 1339
  • [30] A REAL-WORLD ASSESSMENT OF PATIENT CHARACTERISTICS AND TREATMENT PATTERNS AMONG PATIENTS WITH LIPOPROTEIN(A) MEASUREMENT AND RECEIVING PRIMARY AND SECONDARY PREVENTION FOR CARDIOVASCULAR DISEASE IN THE US
    Gautam, Raju
    Mehta, Rina
    Amari, Diana
    Heo, Jihaeng
    Wang, Siwei
    Sung, Jennifer C.
    Cristino, Joaquim
    Wong, Nathan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1562 - 1562